Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1040) Acuvail (ketorolac tromethamine), Allergan,
...Newly Approved Drug Therapies (1040) Acuvail (ketorolac tromethamine), Allergan, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Acuvail (ketorolac tromethamine) Company: Allergan Approval Status: Approved July 2009 Treatment Area: pain and inflammation following cataract ...
View Page

2.  Newly Approved Drug Therapies (334) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan,
...Newly Approved Drug Therapies (334) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Acular (ketorolac tromethamine ophthalmic solution) 0.5% Company: Allergan Approval Status: Approved November 1997 Treatment Area: post ...
View Page

3.  Newly Approved Drug Therapies (218) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan,
...Newly Approved Drug Therapies (218) Acular (ketorolac tromethamine ophthalmic solution) 0.5%, Allergan, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Acular (ketorolac tromethamine ophthalmic solution) 0.5% Company: Allergan Approval Status: Approved January 1997 Treatment Area: Treatment ...
View Page

4.  CenterWatch: Ophthalmology Approved Drug Therapies
...Year   Company   Therapeutic Areas   Drug Names   Approved Drugs for Ophthalmology Drugs Approved in 2009 Acuvail (ketorolac tromethamine) ; Allergan; For the treatment of pain and inflammation following cataract surgery., Approved July 2009 ...
...Pharmaceuticals; Treatment for CMV in AIDS patients, Approved August 1998 Drugs Approved in 1997 Acular (ketorolac tromethamine ophthalmic solution) 0.5% ; Allergan; Treatment for postoperative inflammation in patients who have undergone ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (82), Huntington's Disease
...Analog Scale. This response was superior to placebo and non inferior to approved therapy with Ketorolac. The drug experienced superior onset of pain relief after 5 minutes, compared to Ketorolac, on both the Visual Analog and Categorical scales. This randomized study enrolled 353 patients with ...
View Page

6.  CenterWatch: New Medical Therapies in Disease Category (565), Post-Surgical Pain
...of two doses of Dyloject (18.75 or 37.5 mg) intravenously every six hours, ketorolac 30 mg intravenously every six hours, or placebo. Patient global evaluation scores and related measures ...
...than placebo for all three arms of the study. In addition, when compared to the ketorolac group, the Dyloject groups had a lower incidence of thrombophlebitis, and numerically fewer adverse events ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (215), Neuropathy
...Analog Scale. This response was superior to placebo and non inferior to approved therapy with Ketorolac. The drug experienced superior onset of pain relief after 5 minutes, compared to Ketorolac, on both the Visual Analog and Categorical scales. This randomized study enrolled 353 patients with ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (11), Alzheimer's Disease
...Analog Scale. This response was superior to placebo and non inferior to approved therapy with Ketorolac. The drug experienced superior onset of pain relief after 5 minutes, compared to Ketorolac, on both the Visual Analog and Categorical scales. This randomized study enrolled 353 patients with ...
View Page

9.  CenterWatch: List of Newly Approved Drug Thearapies
...Bristol-Myers Squibb; Treatment for AIDS-related Kaposi's Sarcoma, Approved August 1997 Ophthalmology Acular (ketorolac tromethamine ophthalmic solution) 0.5% ; Allergan; Treatment for postoperative inflammation in patients who have undergone cataract extraction, Approved January 1997 Acular (ketorolac tromethamine ophthalmic solution) 0.5% ; Allergan; Treatment for post-surgical inflammation following cataract extraction, Approved ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (45), Chronic Pain
...with moderate to severe pain following dental extractions. An intravenous bolus dose of 30 mg ketorolac was used as a positive control. The trial compared three doses of M40403 (5, 10 ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (253), Diabetic Neuropathy
...with moderate to severe pain following dental extractions. An intravenous bolus dose of 30 mg ketorolac was used as a positive control. The trial compared three doses of M40403 (5, 10 ...
View Page

12.  CenterWatch: List of Newly Approved Drug Thearapies
...pazopanib) ; GlaxoSmithKline; For the treatment of renal cell carcinoma, Approved October of 2009 Ophthalmology Acuvail (ketorolac tromethamine) ; Allergan; For the treatment of pain and inflammation following cataract surgery., Approved July 2009 ...
View Page

13. September 2009 issue of CenterWatch Monthly, Vol. 16, Iss 09
...Roxro Pharma is in phase II development of ROX-828, an in- tranasal formulation of ketorolac, a non-opioid, non-triptan, non-steroidal anti-inflammatory pain reliever. Its rapid onset of ...
...Pharma (950) 322-4554 www.roxropharma.com a non-opioid, non-triptan, intranasal formulation of ketorolac Phase IIb ADX10059 Addex Pharmaceuticals +41 22 884-155 www.addexpharma.com a selective, negative ...
View Page